PAG
IHE icon

Private Advisor Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Private Advisor Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Sell
3,530
-136
-4% -$11.9K ﹤0.01% 2173
2025
Q4 		$311K Buy
3,666
+110
+3% +$8.78K ﹤0.01% 2136
2025
Q3 		$258K Sell
3,556
-754
-17% -$52K ﹤0.01% 2176
2025
Q2 		$282K Sell
4,310
-344
-7% -$22.4K ﹤0.01% 2016
2025
Q1 		$328K Sell
4,654
-99
-2% -$6.88K ﹤0.01% 1818
2024
Q4 		$312K Sell
4,753
-1,455
-23% -$100K ﹤0.01% 1832
2024
Q3 		$438K Buy
6,208
+141
+2% +$9.82K ﹤0.01% 1694
2024
Q2 		$402K Buy
6,067
+465
+8% +$30.5K ﹤0.01% 1691
2024
Q1 		$380K Buy
5,602
+1,516
+37% +$100K ﹤0.01% 1685
2023
Q4 		$253K Buy
4,086
+399
+11% +$23.4K ﹤0.01% 1895
2023
Q3 		$217K Hold
3,687
– – ﹤0.01% 1828
2023
Q2 		$220K Buy
3,687
+3
+0.1% +$178 ﹤0.01% 1808
2023
Q1 		$215K Buy
+3,684
New +$222K ﹤0.01% 1763
2022
Q3 		– Sell
-3,456
Closed -$221K – 2020
2022
Q2 		$221K Sell
3,456
-309
-8% -$19.6K ﹤0.01% 1792
2022
Q1 		$244K Buy
3,765
+78
+2% +$4.94K ﹤0.01% 1787
2021
Q4 		$245K Sell
3,687
-201
-5% -$12.7K ﹤0.01% 1832
2021
Q3 		$237K Sell
3,888
-216
-5% -$13.7K ﹤0.01% 1810
2021
Q2 		$254K Sell
4,104
-438
-10% -$26.6K ﹤0.01% 1715
2021
Q1 		$269K Hold
4,542
– – ﹤0.01% 1598
2020
Q4 		$272K Buy
4,542
+3
+0.1% +$171 ﹤0.01% 1501
2020
Q3 		$247K Sell
4,539
-657
-13% -$35.4K ﹤0.01% 1332
2020
Q2 		$267K Buy
+5,196
New +$261K ﹤0.01% 1251
2020
Q1 		– Sell
-3,876
Closed -$207K – 1535
2019
Q4 		$207K Buy
+3,876
New +$191K ﹤0.01% 1482
2019
Q3 		– Sell
-4,020
Closed -$202K – 1723
2019
Q2 		$202K Sell
4,020
-225
-5% -$11.1K ﹤0.01% 1508
2019
Q1 		$218K Sell
4,245
-813
-16% -$40.5K ﹤0.01% 1360
2018
Q4 		$237K Buy
5,058
+813
+19% +$41.7K 0.01% 1123
2018
Q3 		$237K Buy
+4,245
New +$232K ﹤0.01% 1356
2018
Q1 		– Sell
-4,209
Closed -$219K – 1259
2017
Q4 		$219K Sell
4,209
-2,310
-35% -$119K 0.01% 1033
2017
Q3 		$345K Sell
6,519
-1,401
-18% -$71.9K 0.01% 1070
2017
Q2 		$407K Buy
7,920
+687
+9% +$34.7K 0.01% 930
2017
Q1 		$361K Sell
7,233
-2,055
-22% -$102K 0.01% 987
2016
Q4 		$446K Buy
9,288
+3,915
+73% +$186K 0.01% 773
2016
Q3 		$269K Sell
5,373
-753
-12% -$38.2K 0.01% 878
2016
Q2 		$302K Sell
6,126
-534
-8% -$25.4K 0.01% 814
2016
Q1 		$304K Sell
6,660
-291
-4% -$13.6K 0.01% 760
2015
Q4 		$375K Buy
6,951
+72
+1% +$3.79K 0.02% 693
2015
Q3 		$339K Sell
6,879
-1,725
-20% -$98.9K 0.02% 685
2015
Q2 		$501K Buy
8,604
+3
+0% +$175 0.02% 595
2015
Q1 		$494K Buy
8,601
+300
+4% +$16.4K 0.03% 560
2014
Q4 		$419K Sell
8,301
-2,895
-26% -$141K 0.03% 602
2014
Q3 		$524K Sell
11,196
-14,814
-57% -$669K 0.04% 502
2014
Q2 		$1.17M Sell
26,010
-1,035
-4% -$44.5K 0.1% 244
2014
Q1 		$1.14M Buy
27,045
+10,155
+60% +$426K 0.12% 203
2013
Q4 		$665K Buy
+16,890
New +$634K 0.07% 317

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Private Advisor Group's IHE Position: Q1 2026 in Review

Private Advisor Group reduced its iShares US Pharmaceuticals ETF (IHE) stake by 3.7% in Q1 2026, selling an estimated $11.9K and leaving 3,530 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Private Advisor Group first reported a position in IHE in Q4 2013 and has held it in 44 quarters since. The position peaked at $1.17M in Q2 2014. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Private Advisor Group held 3,530 shares of iShares US Pharmaceuticals ETF worth $306K as of Q1 2026.
  • Private Advisor Group sold 136 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $11.9K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2173 holding.
  • Private Advisor Group first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and has held it in 44 quarters since.
  • Private Advisor Group's iShares US Pharmaceuticals ETF position peaked at $1.17M in Q2 2014.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.